MyMD Pharmaceuticals Inc (MYMD)

[leifsmith]

Thank you! Patrick Cox and John Mauldin

Patrick Cox was once a writer for Mauldin's newsletters, and at that time Patrick was writing about Star Scientific and its successor, Rock Creek Pharmaceuticals, and their anatabine citrate molecule sold as Anatabloc.

Anatabloc, like MYMD-1, was a TNF-alpha blocker synthesized to match an alkaloid molecule found in tobacco.

The claims being made by MyMD about MYMD-1 are the same as those made for Anatabloc, and the way the two molecules work seems to be similar.

However, Patrick Cox has told me that MYMD-1 is a far superior molecule. In exactly what way is not clear to me yet.

Both molecules owe their origins to some of the same people, including entrepreneur Jonnie Williams, and a group of scientists at Johns Hopkins.

But there are new players in top positions at MyMD, and they seem to know what they are doing.

I'm extremely optimistic about the future of this company.

Pictures of the two molecules, Anatabloc and MYMD-1:



In biology. small insignificant variations in molecules can have enormous consequences. That may be the case here.